Observation of Compliance With Dosage in Women Using Oral Contraceptives Designed for the Non Stop Use, (it Means 28 Pills for 28-days Cycle). (DOC Non Stop)

NCT01185678 COMPLETED

Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Details

Lead sponsor	Bayer
Status	COMPLETED
Enrolment	8416
Start date	2010-05
Completion	2010-11

Conditions

• Contraception

Interventions

• Qlaira or Yaz (BSP products defined as Combined Oral Contraceptive) and Cerazette or Azalia (competitor's products defined as Progestogen Only Pill)

Primary outcomes

• The percentage of users showing noncompliant behaviors — 3 consecutive cycles (28-days per cycle)

Countries

Poland